A major academic research center and three private companies are touting their recently announced functional-genomics consortium as the first of its kind. Officials from the participating entities as well as industry analysts are unsure whether the partnership will inspire similar deals, and they differ on whether it will launch a trend whose net result is more jobs for scientists.
DANGER? Dorin Schumacher of the Consortium for Plant Biotechnology Research warns of a "non- peer-review research funding process."
Interested in reading more?
Become a Member of
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member?